Bupivacaine inhibits cyclic-3',5'-adenosine monophosphate production. A possible contributing factor to cardiovascular toxicity. [electronic resource]
Producer: 19930830Description: 88-95 p. digitalISSN:- 0003-3022
- Adenylyl Cyclases -- metabolism
- Adult
- Amides -- pharmacology
- Bupivacaine -- adverse effects
- Cardiovascular Diseases -- chemically induced
- Colforsin -- pharmacology
- Cyclic AMP -- biosynthesis
- Drug Interactions
- Enzyme Activation -- drug effects
- Epinephrine -- pharmacology
- Female
- GTP-Binding Proteins -- metabolism
- Humans
- Kinetics
- Lymphocytes -- drug effects
- Male
- Mepivacaine -- pharmacology
- Middle Aged
- Models, Biological
- Receptors, Adrenergic, beta -- metabolism
- Ropivacaine
- Signal Transduction -- drug effects
- Stimulation, Chemical
No physical items for this record
Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.